CNBX - Cannabics gets European Patent for personalized medicine drug discovery technology

Cannabics Pharmaceuticals (CNBX) announces that the European Patent Office has granted the company a pharmaceuticals patent for its personalized medicine drug discovery technology.The approved patent is titled: "System and Method for High Throughput Screening of Cancer Cells".Outside the European territory, corresponding patents under the same title have already been granted in Israel and in South Africa, the company said.The company had filed a patent application under the Patent Cooperation Treaty ((PCT)) for novel formulations developed for treatment of various cancer types, earlier this month.

For further details see:

Cannabics gets European Patent for personalized medicine drug discovery technology